Clinical Trials Browser

Phase 2 × Recruiting × Gestational Trophoblastic Disease × Clear all

NCT05139095 2026-02-05

Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia

Phase 2 Recruiting

Gestational Trophoblastic Disease

NCT06790706 2025-10-06

IMMUNORARE5

Phase 2 Recruiting

EndocrineGastrointestinalGynecologicHead & NeckNETThoracic

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Thymoma, Gestational Trophoblastic Disease, Thyroid Carcinoma, Anaplastic

NCT06020755 2024-12-31

TA7

Phase 2 Recruiting

Gestational Trophoblastic Disease

NCT05635344 2024-04-17

A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia

Phase 2 Recruiting

Recurrence, Gestational Trophoblastic Disease

NCT04812002 2022-06-03

Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy

Phase 2 Recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Gestational Trophoblastic Disease